JBT Marel Stock What Raised Guidance And Buybacks Mean

Simply Wall St · 23h ago
  • JBT Marel reported Q3 2026 sales of US$994 million with record adjusted EBITDA margins and higher net income, raised full year EPS and margin guidance, and completed a US$119.97 million buyback covering 1.93% of shares under its May 2026 repurchase plan.
  • The business paired softer revenue in some end markets with tighter cost control and record 18% adjusted EBITDA margins, and announced an expanded US$700 million repurchase authorization that concentrates future earnings power across a smaller share base.
  • We will now explore how JBT Marel's record profitability and larger buyback pool reframes the longer term earnings driven investment narrative.

Scan beyond JBT Marel and spot other companies pairing resilient profitability with disciplined capital returns using the hand picked 35 high quality undervalued stocks screener.

JBT Marel Investment Narrative Recap

To own JBT Marel, you need to be on board with a story that centers on execution. The thesis leans on global protein demand, automation spend, and the company’s plan to turn merger synergies and footprint rationalization into structurally higher profitability. The latest Q3 record 18% adjusted EBITDA margin fits that playbook, even with softer short cycle demand.

The key near term catalyst is whether those cost and integration gains keep offsetting pressure in Prepared Food and Beverage Solutions while tariffs and restructuring costs still bite. The biggest risk is a repeat of past guidance misses. The raised EPS and margin outlook reduces that concern, but does not remove it.

The most relevant recent move is JBT Marel’s decision to complete the US$119.97 million buyback that retired 1.93% of shares, alongside expanding total repurchase authorization to US$700 million. That sits on top of higher earnings guidance and record profitability, so your attention naturally shifts to how much free cash flow the business can produce consistently.

A larger repurchase pool concentrates future earnings on a smaller share count. This can amplify the impact of execution on margins, tariffs, and order flow from protein and poultry projects. The operational story remains the core driver though. If cost programs, service expansion and order conversion stay on track, the capital return framework simply becomes a secondary lever on outcomes.

What JBT Marel’s Long Term Forecasts Assume

Analysts are not just reacting to JBT Marel’s record Q3 profitability and larger buyback pool. They are also anchoring on a multi year model that ties revenue growth, margin expansion and gradual share count reduction into a single earnings path. The numbers behind that story matter if you are trying to judge whether the stock’s capital return plan simply skims excess cash or leans on optimistic forecasts.

In the consensus playbook, JBT Marel is expected to compound sales at 4.2% a year over the next three years while lifting profit margins from 4.9% today to 13.1%. That margin shift does a lot of the heavy lifting. It embeds the expectation that synergy programs and footprint work translate into higher profitability rather than just covering tariffs, restructuring and pricing friction in more cyclical end markets.

Earnings forecasts tell an even sharper story. Analysts project net income to reach US$581.5 million by 2029, up from US$193.3 million today. That is a very large step up in absolute profit and implies meaningful operating leverage if the revenue line only grows at low to mid single digit rates. For context, the current consensus implies roughly a 3x increase in earnings over that period.

The same 2029 framework underpins the way many investors are thinking about JBT Marel’s valuation. To align with the analyst price target, you would need to be comfortable with revenues of about US$4.4b and earnings of US$581.5 million in 2029, coupled with a P/E multiple of 18.9x on those future profits. That prospective multiple sits below the current 28.0x assigned to today’s earnings and below the 24.1x level cited for the broader US Machinery group, which suggests the current narrative leans more on earnings growth than on multiple expansion.

Capital allocation assumptions round out the model. Forecasts build in a modest 0.57% annual decline in the share count over the next three years, consistent with a steady buyback program layered on top of the recently expanded US$700 million authorization. That expected shrink in shares is small each year but becomes more material when paired with the earnings ramp, since it concentrates any future profit pool across a somewhat tighter base.

The link back to the current quarter is straightforward. Record Q3 margins and a completed US$119.97 million repurchase give investors recent evidence for both cost discipline and willingness to return cash. The open question is whether JBT Marel can deliver the margin lift implied in the move from 4.9% to 13.1% while absorbing tariff costs, integration work and any bumps in end market demand across proteins, prepared foods and beverage projects.

JBT Marel's narrative projects US$4.4b revenue and US$581.5 million earnings by 2029. This assumes 4.2% yearly revenue growth and an earnings increase of roughly US$388 million from US$193.3 million today.

Uncover why JBT Marel's fair value indicates a 32% potential upside to its current price that may not last much longer.

NYSE:JBTM 1-Year Stock Price Chart
NYSE:JBTM 1-Year Stock Price Chart

Exploring Other Perspectives

One alternate view puts more weight on JBT Marel’s execution risk. The most cautious analysts were already penciling in revenue of about US$4.4b and earnings near US$606.3 million by 2029, yet only assigning a US$118 price target. That more pessimistic narrative might shift after this buyback and guidance update. You can compare both stories before deciding which feels closer to your own expectations.

Explore 2 other JBT Marel fair value estimates, including one that suggests it could be worth just $167.06!

The Verdict Is Yours

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

Looking For More Investment Ideas Beyond JBT Marel?

Once you have a clear view on JBT Marel, it can help to set it alongside other opportunities that share some of the same qualities such as resilient cash generation, steady balance sheets, or reliable income. The Simply Wall St Screener lets you filter for these traits directly so you can build a watchlist that reflects your own risk and return preferences.